• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Telehealth Could Deliver Over $6B in Healthcare Savings Yearly

by HITC Staff 03/04/2016 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Telemedicine

The global adoption of telehealth technologies will potentially allow governments to make substantial savings on healthcare, while delivering important medical services to both rural and under-served communities, according to business intelligence provider GBI Research.

The company’s latest report* states that the telehealth market is being driven by the accelerated development of mobile technology and applications, a greater need for cost-effective healthcare, rising populations, and increased government funding.

Rishikesh Mandilwar and Rodrigo Gutierrez Gamboa, Managing Analysts at GBI Research and co-authors of the report, state that telehealth is defined as the delivery of healthcare or information at a distance via technology, and includes services such as assessment, monitoring, communications, disease prevention, and education. The Insurance Journal estimates that it could potentially deliver over $6 billion a year in healthcare savings in the US if the technology is widely adopted.

Mandilwar says: “Telehealth could achieve such substantial savings for a number of reasons, including the reduction of re-admissions linked to chronic conditions through mobile health monitoring technologies, a decrease in unnecessary use of emergency appointments through remote visits with nurses, and a lower amount of wasted capacity through telemedicine-based appointments.”

GBI Research’s report also states that the primary inhibitor of telehealth market growth is the cost of setting up appropriate facilities and technologies, meaning poorer countries will witness slower uptake and consequently miss out on the full benefits of telehealth in the short term.

Gutierrez Gamboa explains: “Data security concerns and privacy issues, as well as a lack of IT literacy in some developing economies, are some of the major issues currently hindering growth in the market.

“Despite this, there is a wealth of opportunities to be exploited in the market. If telehealth providers are to realize these opportunities, they will have to develop compelling commercial models that seamlessly place their services within a wider system of integrated healthcare.

“Currently, the telemedicine and mobile health segments of the market are the ones to focus on, as they are some of the most promising and fast-growing across the board.”

The analysts add that key players in the overall telehealth space include 3M, Aerotel Medical Systems, AMD Global Telemedicine, CardioComm, Honeywell HomMed, and Philips Healthcare.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |